|
|
Third DNA Damage Pathway Found.(Brief Article)(Editorial)
- Article from:
-
Genomics and Proteomics
- Article date:
-
January 1, 2005
- Author:
-
|
Copyright informationCOPYRIGHT 2005 Advantage Business Media. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
By Elizabeth Tolchin, News Editor
New research suggests that blocking a particular protein may make it possible to increase the sensitivity of cancer cells to chemotherapeutic agents, allowing dose decreases and thus limiting the toxic side effects associated with high doses. The researchers used RNA interference (RNAi) to demonstrate their theory.
The work, performed by researchers from the Massachusetts Institute of Technology Center for Cancer Research, led by Michael Yaffe, MD, PhD, associate professor of biology, points to a protein called MAPKAP kinase-2.
"MAPKAP kinase-2 was thought to be primarily involved in inflammation, and both Wyeth [Pharmaceuticals, ...